Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer to invest $200m in Irish biomanufacturing plant

September 21, 2011
Manufacturing and Production Ireland, Pfizer, pharma manufacturing news

Pfizer is planning to invest around €145 million ($200m) at its biomanufacturing facility in Co Dublin, Ireland, according to the …

News
Janssen's Zytiga

Janssen’s Zytiga launched in the UK

September 21, 2011
Sales and Marketing Zytiga, prostate cancer

Janssen’s new advanced prostate cancer treatment Zytiga has been launched in the UK. Zytiga (abiraterone acetate) has been shown in …

News

Pharmacovigilance Compliance Report submission; MHRA’s Risk Based Compliance Programme

September 20, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PV, Wainwright Associates

A new version of the MHRA pharmacovigilance Compliance Report (Good Pharmacovigilance Practice Questionnaire) has been released by the MHRA.Submission of …

News
Press release

Roche to show new cancer data at European congress

September 20, 2011
Research and Development Cancer, Roche, T-DM1, Zelboraf, avastin

Roche will highlight a range of new approaches in targeting cancer at the upcoming European cancer conference. In a series …

News
Boehringer Ingelheim

Boehringer’s Trajenta launched in the UK

September 20, 2011
Sales and Marketing Boehringer, Trajenta, diabetes

Boehringer Ingelheim has launched its new diabetes drug Trajenta in the UK, with a price tag to match its rival …

News

Teva makes commitment to Russian manufacturing facility

September 20, 2011
Manufacturing and Production, Sales and Marketing Russia, Teva

Teva has joined a number of its peers in the pharmaceutical sector and announced plans to build a new manufacturing …

News

Intersex fish add to concerns about pharma wastewater

September 20, 2011
Business Services, Manufacturing and Production Contamination, pharma manufacturing news

Researchers in France have discovered that wild fish living downstream from a pharmaceutical production plant making steroid drugs show serious …

News
Merck Serono

Merck licences new MS drug

September 19, 2011
Research and Development Cladribine, Merck KGaA, Merck Serono, PI-2301

Merck KGaA has in-licensed a new multiple sclerosis drug and aims to start it in phase II studies later this …

News

Alkermes and Elan Drug Technologies complete merger

September 19, 2011
Manufacturing and Production Alkermes, Elan, pharma manufacturing news

The contract manufacturing and development unit of Irish drugmaker Elan has completed a near-$1 billion merger with drug delivery specialist …

News
zealand_pharma_dr_arvind_hundal

Dr Arvind Hundal joins Zealand Pharma

September 19, 2011
Sales and Marketing appointment, sales and marketing

Zealand Pharma has boosted its executive management team with the appointment of Dr Arvind Hundal as chief business officer. She …

Appointment

ArcMedia appoints communications coaches

September 19, 2011
Medical Communications, Sales and Marketing appointment, medical communications, sales and marketing

UK speaker training agency ArcMedia has appointed new communications consultants Linda Gummery and Charlotte Hume. Linda spent eight years leading …

Appointment

Working Life: Graham Morris from BMS

September 19, 2011
Sales and Marketing Working Life

Bristol-Myers Squibb’s CV/Metabolics business unit director Graham Morris on how his field is changing and the best, and worst, things …

News
Roche's Avastin

Cancer Fund improving treatment access

September 19, 2011
Sales and Marketing Cancer Drugs Fund, postcode prescribing

The Cancer Drugs Fund is dramatically improving access to new cancer medicines for patients in England – but its success …

News

Melanoma: new treatments and hopes

September 19, 2011
Research and Development advanced melanoma, melanoma, skin cancer

It usually starts with a subtle change of colour or shape in an existing mole. But if left undiagnosed and …

Feature

Eliquis launched in the UK

September 19, 2011
Sales and Marketing Eliquis, Pradaxa, VTE, Xarelto

Eliquis, the latest entrant to the competitive oral anticoagulant market, has been launched in the UK.Co-developed and co-marketed by Pfizer …

News
GSK McLaren

McLaren alliance to turbocharge GSK research

September 16, 2011
Manufacturing and Production, Research and Development GSK, manufacturing and production news, pharma manufacturing news, research and development news

GlaxoSmithKline has turned to the engineering expertise of Formula 1 racing team McLaren in an innovative alliance designed to transform …

News

UK-funded science research must be made more accessible, says minister

September 16, 2011
Medical Communications, Research and Development UK science

Research paid for by the UK taxpayer must be made more accessible to the public, researchers and other stake holders, …

News

Positive results for phase II malaria vaccine

September 16, 2011
Research and Development malaria, malaria vaccine

Researchers in the US and West Africa believe they have identified the first effective blood-stage malaria vaccine, a development which …

News

Edelman appoints new head of digital health

September 16, 2011
Medical Communications appointment, medical communications

Edelman has appointed Dave Pinnington as head of digital health for Europe to lead the development of the PR firm’s …

Appointment

Firstlight launches new health offering

September 16, 2011
Medical Communications Firstlight, medical communications news

London-based PR agency Firstlight has set up a new healthcare arm and appointed Pat Pearson to lead it. He is …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026